Skip to contentI
Innoviva, Inc.
I
INVAInnoviva, Inc. Q3 2024 · 10-Q
Revenue$89.51M$89.51M+33.1% vs Q3 2023 Net Income$1.21M$1.21M−98.5% vs Q3 2023 EPS Diluted$0.02$0.02−98.0% vs Q3 2023 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
Operating Cash Flowderived$48,686,000+10.8% Free Cash Flowderived$48,416,000+10.8% Margins · derivedGross margin81.6%
Operating margin48.3%
Net margin1.4%−120.6 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 6, 2024 · 37 d after period end